NVCR

Novocure Stock Analysis

AI Rating

Neutral
  • Quality2/10
  • Growth 6/10
  • Value 1/10
Novocure sales and earnings growth
NVCR Growth
Good
  • Revenue Y/Y 8.28%
  • EPS Y/Y 21.79%
  • FCF Y/Y -9.32%
Novocure gross and profit margin trends
NVCR Profitability
Fair
  • Gross margin 74.50%
  • EPS margin -20.80%
  • ROIC 5Y -14.84%
Novocure net debt vs free cash flow
NVCR Risk
Great
  • Debt / Equity 0.7
  • Debt / FCF 1.8
  • Interest coverage -8.8

Novocure stock volatility is in-line with the overall market. We give it a Great risk rating.

More Medical Devices stocks ↗